Drug Shortage Report for TIMOLOL MALEATE-EX
Report ID | 227853 |
Drug Identification Number | 02242275 |
Brand name | TIMOLOL MALEATE-EX |
Common or Proper name | TIMOLOL MALEATE-EX |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL |
Strength(s) | 0.25% |
Dosage form(s) | SOLUTION (EXTENDED RELEASE) |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-05-13 |
Estimated end date | 2025-03-21 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-12-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2024-12-10 | French | Compare |
v16 | 2024-12-10 | English | Compare |
v15 | 2024-09-30 | French | Compare |
v14 | 2024-09-30 | English | Compare |
v13 | 2024-09-16 | French | Compare |
v12 | 2024-09-16 | English | Compare |
v11 | 2024-07-29 | French | Compare |
v10 | 2024-07-29 | English | Compare |
v9 | 2024-07-02 | French | Compare |
v8 | 2024-07-02 | English | Compare |
v7 | 2024-06-25 | French | Compare |
v6 | 2024-06-25 | English | Compare |
v5 | 2024-06-12 | French | Compare |
v4 | 2024-06-12 | English | Compare |
v3 | 2024-05-14 | English | Compare |
v2 | 2024-05-13 | French | Compare |
v1 | 2024-05-13 | English | Compare |
Showing 1 to 17 of 17